GLUE 8-K 2026-10-01

Monte Rosa Therapeutics, Inc. (GLUE) 8-K dated 2026-10-01 — accession 0001193125-26-409833. This URL is the filing, not the GLUE hub.

Monte Rosa Therapeutics, Inc. (GLUE) is a biotechnology company listed on NASDAQ.

Monte Rosa Therapeutics, Inc. filed a 8-K on 2026-10-01. Accession 0001193125-26-409833.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. Revenue was up 63.5% from 2024-12-31 to 2025-12-31. GLUE currently screens at market cap $1.56B.

Not investment advice. The GLUE SEC hub lists recent forms. The stock page is the research view.